Works matching IS 09255710 AND DT 2023 AND VI 118 AND IP 4
Results: 15
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 462, doi. 10.1007/s12185-023-03648-1
- By:
- Publication type:
- Article
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 443, doi. 10.1007/s12185-023-03647-2
- By:
- Publication type:
- Article
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Substitution of calcineurin inhibitors with corticosteroids after allogeneic hematopoietic cell transplantation.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 450, doi. 10.1007/s12185-023-03645-4
- By:
- Publication type:
- Article
Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 432, doi. 10.1007/s12185-023-03634-7
- By:
- Publication type:
- Article
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 419, doi. 10.1007/s12185-023-03630-x
- By:
- Publication type:
- Article
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 483, doi. 10.1007/s12185-023-03623-w
- By:
- Publication type:
- Article
Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 514, doi. 10.1007/s12185-023-03622-x
- By:
- Publication type:
- Article
Transcriptome sequencing identifies novel EVX fusions involved in transcriptional activation of HOX family genes in pediatric immature T-cell acute lymphoblastic leukemia: two cases reports and a literature review.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 508, doi. 10.1007/s12185-023-03619-6
- By:
- Publication type:
- Article
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 477, doi. 10.1007/s12185-023-03618-7
- By:
- Publication type:
- Article
Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 519, doi. 10.1007/s12185-023-03613-y
- By:
- Publication type:
- Article
A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 472, doi. 10.1007/s12185-023-03608-9
- By:
- Publication type:
- Article
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 503, doi. 10.1007/s12185-023-03607-w
- By:
- Publication type:
- Article
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 494, doi. 10.1007/s12185-023-03598-8
- By:
- Publication type:
- Article
Mutated ZRSR2 and CUL3 accelerate clonal evolution and confer venetoclax resistance via RAS signaling pathway in blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 489, doi. 10.1007/s12185-023-03597-9
- By:
- Publication type:
- Article